Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face

NCT02723721 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lentigo Maligna

Interventions

DRUG: Picato gel

Sponsor

Centre Hospitalier Universitaire de Nice